RXST Insider Trading
Insider Ownership Percentage: 9.57%
Insider Buying (Last 12 Months): $549,098.81
Insider Selling (Last 12 Months): $3,844,126.44
RxSight Share Price & Price History
Current Price: $7.28
Price Change: ▼ Price Decrease of -0.075 (-1.02%)
As of 07/22/2025 04:58 PM ET
RxSight Insider Trading History
RxSight Institutional Trading History
Data available starting January 2016
RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.
Read More on RxSight
Volume
728,943 shs
Average Volume
822,976 shs
Market Capitalization
$295.66 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.21
Who are the company insiders with the largest holdings of RxSight?
RxSight's top insider shareholders include:
- Bakker Juliet Tammenoms (Director)
- Ronald M Md Kurtz (CEO)
- Jesse Anderson Corley (Director)
- Eric Weinberg (Insider)
- Ilya Goldshleger (Insider)
- Julie Andrews (Director)
- Robert Keith Warner (Director)
- Ilya Goldshleger (COO)
- Shweta Maniar (Director)
- Tamara Fountain (Director)
- William J Phd Link (Director)
- Shelley B Thunen (CFO)
Learn More about top insider investors at RxSight.
Who are the major institutional investors of RxSight?
Which major investors are buying RxSight stock?
Within the previous quarter, RXST stock was bought by institutional investors including:
- Tempus Wealth Planning LLC
Within the last year, these company insiders have bought RxSight stock:
- Bakker Juliet Tammenoms (Director)
- Ronald M Md Kurtz (CEO)
Learn More investors buying RxSight stock.